Administrative Core

行政核心

基本信息

  • 批准号:
    10225989
  • 负责人:
  • 金额:
    $ 16.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

This P50 application represents a novel interdisciplinary center at the intersection of behavioral economics and implementation science in pursuit of improving cancer care delivery. The Administrative Core for the University of Pennsylvania Implementation Science Center in Cancer Control (Penn ISC3) will provide overarching operational and scientific oversight. It will be led by the three Penn ISC3 Principal Investigators, Drs. Beidas, Bekelman, and Schnoll, in collaboration with an Internal Executive Committee and an External Advisory Board. The Specific Aims of the Administrative Core are as follows: 1) To provide essential management and integration of Penn ISC3 activities (operational structure),which will include administrative support, meeting coordination, and ensuring the effective use of the Internal Executive Committee and an External Advisory Board; (2) To serve as the hub for implementation science (IS) research in cancer at Penn (IS outreach), which will involve coordination of educational activities, drawing upon essential partnerships at Penn, engage in activities to ensure communication, engaging with other centers funded through this mechanism, and coordinating an annual retreat; (3) To coordinate communication and dissemination of the Center’s research findings, build research capacity and collaboration with other Moonshot awardees, and support a national implementation science and cancer research community (network unit); and (4) To support, monitor, and evaluate Center progress (evaluation unit), which will ensure completion of proposed studies, determine the broader impact of the Center, and help to translate the results of the proposed studies into subsequent funded research projects. The overarching priority for the Administrative Core is to ensure that the impact of the Penn ISC3 is robust and greater than the sum of its parts. It will do so by coordinating services and maximizing synergies among the Research Program, Implementation Laboratory, and other center activities. The Administrative Core will interface with the Research Program (Project PIs and Methods Unit) regularly to ensure that each entity is meeting goals and objectives, and problem solve as necessary. The proposed Penn ISC3 will bring together junior and senior investigators from multiple disciplines, which will create a fertile environment with the long-term goal of improving cancer care delivery and exerting a sustained impact on public health in partnership with key stakeholders. Ultimately, the Penn ISC3 Administrative Core will create a culture of exceptional science and ensure the Center’s success by stimulating and guiding new conceptual and methodological advancements, supporting the growth of IS and cancer research at Penn and nationally, and advancing the science of implementation within oncology care. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
这个P50应用程序代表了一个新的跨学科中心,在行为经济学和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rinad Sary Beidas其他文献

Rinad Sary Beidas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rinad Sary Beidas', 18)}}的其他基金

Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
与 FH 基金会合作,利用行为经济学对家族性高胆固醇血症患者公平地实施级联筛查
  • 批准号:
    10585100
  • 财政年份:
    2022
  • 资助金额:
    $ 16.86万
  • 项目类别:
Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
与 FH 基金会合作,利用行为经济学对家族性高胆固醇血症患者公平地实施级联筛查
  • 批准号:
    10367999
  • 财政年份:
    2022
  • 资助金额:
    $ 16.86万
  • 项目类别:
Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial
消除显示器过度使用 (EMO) 混合有效性-取消实施试验
  • 批准号:
    10689754
  • 财政年份:
    2021
  • 资助金额:
    $ 16.86万
  • 项目类别:
Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial
消除显示器过度使用 (EMO) 混合有效性-取消实施试验
  • 批准号:
    10315079
  • 财政年份:
    2021
  • 资助金额:
    $ 16.86万
  • 项目类别:
A Comparative Effectiveness Trial of Strategies to Implement Firearm Safety Promotion as a Universal Suicide Prevention Strategy in Pediatric Primary Care
将枪支安全促进作为儿科初级保健中普遍自杀预防策略实施的策略的比较有效性试验
  • 批准号:
    10663829
  • 财政年份:
    2020
  • 资助金额:
    $ 16.86万
  • 项目类别:
Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science
通过行为经济学和实施科学提高癌症护理质量
  • 批准号:
    10683403
  • 财政年份:
    2020
  • 资助金额:
    $ 16.86万
  • 项目类别:
A comparative effectiveness trial of strategies to implement firearm safety promotion as a universal suicide prevention strategy in pediatric primary care
将枪支安全促进作为儿科初级保健中普遍自杀预防策略实施的策略的比较有效性试验
  • 批准号:
    10448721
  • 财政年份:
    2020
  • 资助金额:
    $ 16.86万
  • 项目类别:
A Comparative Effectiveness Trial of Strategies to Implement Firearm Safety Promotion as a Universal Suicide Prevention Strategy in Pediatric Primary Care
将枪支安全促进作为儿科初级保健中普遍自杀预防策略实施的策略的比较有效性试验
  • 批准号:
    10715802
  • 财政年份:
    2020
  • 资助金额:
    $ 16.86万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10931118
  • 财政年份:
    2020
  • 资助金额:
    $ 16.86万
  • 项目类别:
Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers: A Stepped Wedge Hybrid Type II Effectiveness Implementation Trial
社区卫生工作者提供的针对 ART 依从性和 HIV 护理保留的管理问题解决:阶梯楔形混合 II 型有效性实施试验
  • 批准号:
    10432088
  • 财政年份:
    2020
  • 资助金额:
    $ 16.86万
  • 项目类别:

相似海外基金

Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes
使用模拟禁食饮食进行间歇性禁食以改善前列腺癌控制和代谢结果
  • 批准号:
    10639416
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
Multidimensional structural racism and moderating role of psychosocial resources on cancer-control behaviors in African Americans
多维结构性种族主义和心理社会资源对非裔美国人癌症控制行为的调节作用
  • 批准号:
    10798610
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
Training Grant in Precision Cancer Control
精准癌症控制培训补助金
  • 批准号:
    10768785
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
STAKEHOLDER ENGAGEMENT AND OUTREACH SUPPORT FOR HEALTH BEHAVIOR CHANGE AND CANCER CONTROL RESOURCES
利益相关者参与和外展支持健康行为改变和癌症控制资源
  • 批准号:
    10929022
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
DIVISION OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS) BIOMEDICAL COMPUTING SUPPORT SERVICES_ Moonshot Support
癌症控制和人口科学部 (DCCPS) 生物医学计算支持服务_ Moonshot 支持
  • 批准号:
    10975530
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia
为赞比亚艾滋病毒感染者提供综合癌症控制干预措施
  • 批准号:
    10878015
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
Cancer Control and Population Sciences Research Program
癌症控制与人口科学研究计划
  • 批准号:
    10625755
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
Development of Combination Radiation Therapy Drugs to Improve Cancer Control Rates by Regulating DNA Damage Response Molecules
开发组合放射治疗药物,通过调节 DNA 损伤反应分子来提高癌症控制率
  • 批准号:
    23H02859
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Improving access to cancer control services in low- and middle-income countries; a novel framework on policy change for pharmacists' involvement
改善低收入和中等收入国家获得癌症控制服务的机会;
  • 批准号:
    490927
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference
2023年加拿大癌症控制应用研究中心(ARCC)会议
  • 批准号:
    480786
  • 财政年份:
    2023
  • 资助金额:
    $ 16.86万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了